Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion type Assertion NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_head.
- NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion description "[Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NF?B) along with the increased circulatory levels of TNF-? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_provenance.
- NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion evidence source_evidence_literature NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_provenance.
- NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion SIO_000772 24018334 NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_provenance.
- NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion wasDerivedFrom befree-20150227 NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_provenance.
- NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_assertion wasGeneratedBy ECO_0000203 NP589925.RA9FiSD3uGS42QRiYsBw6z9orCQT-PbZWW80IaPCI6sHI130_provenance.